跳至主要内容
临床试验/NCT06928649
NCT06928649招募中不适用

Innovative Cell Death Diagnostics Allowing Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies

University Hospital, Antwerp2 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2024年3月13日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
600
试验地点
2
主要终点
Number of patients with survival after 28 days.

研究概览

简要总结

In order to better determine which therapy is best for patiënts which present with organ falure during the course of their stay in the intesive care unit (ICU) , one has to determine which underlying mechanism is causing this organ falure. We will determine levels of so called "biomarkers" for ferroptosis (a mechan ism of iron-related cell death) in the peripheral blood and biological fluids of criticaly ill patients admitted to the ICU with a catastrrophy (severe infection, trauma ...) . Why ? If it turns out that this ferroptosis plays a role in the ocurrence of organ failure in the critially ill, this will lead to new therapies in the future as drugs become more and more available which can influene this biochemical "pahway". of iron-relatd death.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admitted to the ICU of UZA
  • Critically ill and predicted to be hospitalised in the ICU for > 48 hours (i.e. mostly patients admitted for sepsis, trauma, haemorrhagic shock, neurological catastrophe ... which means at risk to develop mono-or multiple organ failure)
  • With arterial line in place (for blood sampling)

排除标准

  • Refusal of consent by patient or closest relative
  • Postoperative patients after major surgery in whom prolonged ICU stay is not foreseen (i.e. elective cardiac surgery

结局指标

主要结局

Number of patients with survival after 28 days.

时间窗: 28 days

Survival in and after ICU.

次要结局

  • Change from baseline concentration of Norepinephrine every day during ICU stay(28 days)
  • Change in SOFA score during ICU stay(Change from enrollment to 14 days of ICU stay)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Philppe Jorens

Prof.

University Hospital, Antwerp

研究点 (2)

Loading locations...

相似试验